JP2023520990A5 - - Google Patents

Info

Publication number
JP2023520990A5
JP2023520990A5 JP2022558198A JP2022558198A JP2023520990A5 JP 2023520990 A5 JP2023520990 A5 JP 2023520990A5 JP 2022558198 A JP2022558198 A JP 2022558198A JP 2022558198 A JP2022558198 A JP 2022558198A JP 2023520990 A5 JP2023520990 A5 JP 2023520990A5
Authority
JP
Japan
Prior art keywords
cell epitope
cell
seq
composition
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022558198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520990A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/024352 external-priority patent/WO2021195492A1/en
Publication of JP2023520990A publication Critical patent/JP2023520990A/ja
Publication of JP2023520990A5 publication Critical patent/JP2023520990A5/ja
Pending legal-status Critical Current

Links

JP2022558198A 2020-03-27 2021-03-26 制御性ｔ細胞エピトープ Pending JP2023520990A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063000630P 2020-03-27 2020-03-27
US63/000,630 2020-03-27
US202063077253P 2020-09-11 2020-09-11
US63/077,253 2020-09-11
PCT/US2021/024352 WO2021195492A1 (en) 2020-03-27 2021-03-26 Regulatory t cell epitopes

Publications (2)

Publication Number Publication Date
JP2023520990A JP2023520990A (ja) 2023-05-23
JP2023520990A5 true JP2023520990A5 (https=) 2024-04-04

Family

ID=77890731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022558198A Pending JP2023520990A (ja) 2020-03-27 2021-03-26 制御性ｔ細胞エピトープ

Country Status (8)

Country Link
US (2) US11911414B2 (https=)
EP (1) EP4126901A4 (https=)
JP (1) JP2023520990A (https=)
KR (1) KR20220160640A (https=)
AU (1) AU2021242326A1 (https=)
CA (1) CA3172976A1 (https=)
MX (1) MX2022011982A (https=)
WO (1) WO2021195492A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4086179B2 (ja) * 2001-06-28 2008-05-14 明治乳業株式会社 封入体からの多重ｔ細胞エピトープポリペプチドの精製法。
RU2006122946A (ru) * 2003-11-28 2008-01-10 Астразенека Аб (Se) Антитела
EP2450368A1 (en) 2007-01-30 2012-05-09 Epivax, Inc. Regulatory t cell epitopes, compositions and uses thereof
WO2019071116A1 (en) * 2017-10-05 2019-04-11 Epivax, Inc. T REGULATORY LYMPHOCYTE EPITOPES
KR102602329B1 (ko) * 2018-05-23 2023-11-16 화이자 인코포레이티드 Cd3에 특이적인 항체 및 이의 용도

Similar Documents

Publication Publication Date Title
KR102482994B1 (ko) 사스-코로나바이러스-2 감염증 예방 또는 치료용 백신 조성물
JP2023513720A5 (https=)
JP2001517069A (ja) 結核の免疫治療および診断のための化合物および方法
ES2199932T3 (es) Poxvirus recombinante y vacuna estreptococica que contiene proteina m.
JP7146926B2 (ja) Ｃｄ４ヘルパーｔ細胞エピトープの融合ペプチドおよびそのワクチン
JP7072921B2 (ja) Ａ群レンサ球菌ワクチン
JP2005508143A (ja) アジュバントとしてのコレラホロトキシンの突然変異形
JP2010516290A5 (https=)
JP2003529319A (ja) ＨＩＶ−１ｇｐ４１を標的化する広範に中和する抗体を誘発する方法
Solioz et al. The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis
CN111961138A (zh) 疫苗融合蛋白
TWI621627B (zh) 用於豬生殖與呼吸綜合症及豬環狀病毒關聯疾病之疫苗組成物
Ni et al. Protection against scrub typhus by a plasmid vaccine encoding the 56-KD outer membrane protein antigen gene
JP2010535504A5 (https=)
JP2023522198A5 (https=)
WO2018037246A1 (en) Immunogenic composition
JP2023520990A5 (https=)
CN109369809B (zh) 多表位抗原及其制备方法与在制备防治鹦鹉热衣原体感染的药物中的应用
EP3713600B1 (en) Synthetic hemagglutinin as universal vaccine against infection by type b influenza viruses (ibv)
CN119144656A (zh) 汉坦病毒抗原组合物
US11116837B2 (en) Vaccine composition comprising hepatitis B virus like particle as adjuvant
JP2018505697A5 (https=)
CN102219858A (zh) 微小隐孢子虫ctl多表位基因和融合蛋白及其应用
CN101880328B (zh) 微小隐孢子虫Th多表位基因和融合蛋白及其应用
WO2023279771A1 (zh) 一种抗多发性硬化的重组蛋白及其制备方法和用途